Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

1.7K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CPM-XNet: Annotation-Efficient Deep-Learning Framework for Detecting Tuberculosis in Chest X-Ray Images.

Diagnostics (Basel, Switzerland)·2026
Same author

Segmentation of uterus and myoma from MRI image based on deep learning.

Taiwanese journal of obstetrics & gynecology·2026
Same author

Factors influencing Anti-SARS-CoV-2 IgG levels after vaccination in breast cancer patients.

Discover oncology·2026
Same author

Inhibitory Effects of Syringic Acid on Endometrial Cancer Cell Growth and Migration and Its Synergistic Suppression with Doxorubicin.

Pharmaceuticals (Basel, Switzerland)·2025
Same author

Leveraging AI for facioscapulohumeral muscular dystrophy prediction and omics biomarker identification.

bioRxiv : the preprint server for biology·2025
Same author

The diguanylate cyclase and phosphodiesterase locally regulate the virulence factors in Vibrio vulnificus.

Gut pathogens·2025

Related Experiment Video

Updated: Nov 25, 2025

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
06:51

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Published on: August 10, 2018

7.9K

A rapid molecular diagnostic method for spinal muscular atrophy.

Kai-Chen Wang1,2, Chiao-Yuan Fang3, Chi-Chang Chang4

  • 1Cheng-Hsin General Hospital, Taipei, Taiwan.

Journal of Neurogenetics
|December 17, 2020
PubMed
Summary

A new digital PCR method accurately detects spinal muscular atrophy (SMA) by analyzing survival motor neuron (SMN) gene copy numbers. This rapid test aids in early diagnosis for carriers and patients, improving genetic screening outcomes.

Keywords:
Digital PCRSMASMN1SMN2

More Related Videos

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
05:16

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Published on: May 7, 2020

7.1K
Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
09:18

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy

Published on: January 12, 2019

10.6K

Related Experiment Videos

Last Updated: Nov 25, 2025

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
06:51

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Published on: August 10, 2018

7.9K
Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
05:16

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Published on: May 7, 2020

7.1K
Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
09:18

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy

Published on: January 12, 2019

10.6K

Area of Science:

  • Genetics
  • Molecular Biology
  • Medical Diagnostics

Background:

  • Spinal muscular atrophy (SMA) is a prevalent autosomal recessive disorder and a leading cause of infant mortality.
  • SMA results from deficiency in the survival motor neuron 1 (SMN1) gene, leading to severe motor neuron degeneration.
  • Current diagnostic methods for SMA can be time-consuming and complex.

Purpose of the Study:

  • To develop and validate a fast, accurate, and robust method for detecting SMA.
  • To determine the copy numbers of SMN1 and SMN2 genes for precise SMA diagnosis.
  • To establish reliable cut-off ranges for differentiating unaffected individuals, SMA carriers, and SMA patients.

Main Methods:

  • Utilized the Clarity™ Digital PCR (dPCR) System for quantifying SMN1 and SMN2 gene copy numbers from various genomic DNA sources.
  • Established diagnostic cut-off ranges using 214 clinical samples previously analyzed by qPCR.
  • Validated the dPCR method against MLPA (multiplex ligation-dependent probe amplification), the current gold standard, using 12 clinical samples.

Main Results:

  • The dPCR method demonstrated high accuracy in determining SMN gene copy numbers.
  • 100% concordance was achieved between the dPCR-based method and MLPA analysis for the 12 tested samples.
  • The CSB SMA Detection Kit combined with dPCR provides a precise approach for SMA classification.

Conclusions:

  • The developed dPCR method offers a rapid and reliable diagnostic tool for SMA detection.
  • This method can be integrated into pre-pregnancy screening, prenatal testing, and newborn screening programs.
  • Improved SMA incidence management and genetic counseling are anticipated with this advanced diagnostic approach.